Skip to main content
. 2022 Oct 17;10(10):e005158. doi: 10.1136/jitc-2022-005158

Figure 1.

Figure 1

Flow chart showing trial selection procedure. Note: no eligible trial was identified in Chinese biomedical databases. EGFR, epidermal growth factor receptor; HPV, human papillomavirus; ORR, objective response rate; PD-1, programmed cell death protein 1.